Trilostane is an inhibitor of 3 beta-hydroxysteroid dehydrogenase used in the treatment of Cushing's syndrome. It was withdrawn from the United States market in April 1994.
用于治疗皮质醇增多症(库欣综合征),也可用于醛固酮增多症和高雄激素血症。
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.